Share-based Payment Arrangement, Expense of Alto Neuroscience, Inc. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alto Neuroscience, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2023 to 30 Sep 2025.
  • Alto Neuroscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,189,000, a 9.6% increase year-over-year.
  • Alto Neuroscience, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $7,728,000, a 16% increase year-over-year.
  • Alto Neuroscience, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7,631,000, a 164% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Alto Neuroscience, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,728,000 $2,189,000 +$191,000 +9.6% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $7,537,000 $2,005,000 +$117,000 +6.2% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $7,420,000 $1,968,000 -$211,000 -9.7% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $7,631,000 $1,566,000 +$960,000 +158% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $6,671,000 $1,998,000 +$1,457,000 +269% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $5,214,000 $1,888,000 +$628,000 +50% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $4,586,000 $2,179,000 +$1,695,000 +350% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $2,891,000 $606,000 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $541,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,260,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $484,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1

Alto Neuroscience, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,631,000 +$4,740,000 +164% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $2,891,000 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.